Tullia Bruno

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Tullia Bruno

Mar 3, 2025, 15:51 | Science

Patrick Hwu: Are B cells important to eliminate cancers?

Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on LinkedIn about…

Dec 3, 2024, 05:11 | Blog

Tullia Bruno: Summary of our work presented at Multiomics 2024

Tullia Bruno, Assistant Professor at the University of Pittsburgh, posted the following on X: “What…

Oct 31, 2024, 14:31 | Blog

Development of TLS in different tumor sites from patients with high-grade serous ovarian cancer - Cancer Research Institute

Cancer Research Institute shared a post on LinkedIn: "Aiming to improve the understanding of immune…

Sep 14, 2024, 06:36 | Societies

13 Posts Not To Miss From CICON24

The Eighth International Cancer Immunotherapy Conference (CICON24) took place from September 8 to 11, 2024,…

Aug 9, 2024, 12:57 | Insight

Tony Cillo: Excited to share our paper on anti-PD1+anti-LAG3 therapy in melanoma

Tony Cillo, Assistant professor in the Department of Immunology at the University of Pittsburgh. "Excited…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023